The latest appointment for Pfizer's oncology business

Recently, Pfizer's Rare Diseases and Oncology business group and the oncology business group 2 welcomed the new appointment.
Rare Diseases and Oncology Group of colleagues will report directly to Ms. Li Xueqin, Senior Sales Director of Pfizer Biopharmaceutical Group China Rare Diseases and Oncology Business Group: Ms. Cai Guo, Senior Medical Letter Communication Regional Manager, RCCGI South Region, Location: Guangzhou.
is responsible for sales management of RCCGI product lines in Shanghai, Guangdong, Guangxi, Zhejiang, Fujian, Jiangxi, Henan, Hubei, Hunan, Yunnan, Guizhou, Sichuan and Chongqing.
, Ms. Cai Guo, graduated with a Bachelor of Engineering degree in Biopharmaceuticals from China Pharmaceutical University.
Pfizer as regional manager in 2015 and was promoted to regional manager in 2018.
During her time in office, Ms. Cai has accumulated extensive experience in sales management and strategy development, focusing on the creation and talent development of high-performance teams, delivering talent to different product lines, continuously leading the team to drive business innovation and continuously breaking milestones.
Zhu Wei, Senior Medical Information Communication Regional Manager, Shanghai, responsible for the sales of the national blood product line.
Graduated from Zhejiang University of Technology with a master's degree in bioengineering and 15 years of work experience in the industry.
joined Pfizer in 2009 as a sales specialist, has a wealth of product line sales experience and sales management experience, has MICS, DM, RM, the former Blood South Regional Manager, in the delivery results, strategic thinking, talent development, innovation and development, platform construction and other aspects of outstanding leadership, and continue to lead the team to achieve great results.
Oncology Business Group 2 Colleagues will report directly to Mr. Yue Jie, Sales Director of Pfizer Biopharmaceutical Group China Group II: Mr. Tian Xiaojia, Senior Medical Information Communication Regional Manager, Cancer Business Group II North District, Beijing.
Xiaojia graduated from Shenyang Pharmaceutical University with a clinical degree.
joined Pfizer in 2007 and has served as Medical Information Communications Specialist, Regional Manager, Regional Promotion Manager, Regional Manager, etc., where he has been responsible for sales, regional markets and training in cardiovascular, anti-infectant, tumor and other fields.
Ma Jun, Manager of Medical Information Communication Area, North Second District, Oncology Business Group II, Shenyang.
responsible for shandong, Henan, Heilongjiang, Jilin, Liaoning, Inner Mongolia breast tumor product line sales management.
Ma Jun graduated from Shenyang Agricultural University with a major in biotechnology and joined Pfizer as Regional Manager of The Tumor Team Heji in 2017 and was promoted to Regional Manager of North 2nd District in June 2019, leading the team to achieve sustained high growth.
Yujun, Manager of Medical Information Communication Area, East District, Group II of Oncology Business, Shanghai.
is responsible for the sales management of breast tumor product lines in Shanghai, Jiangsu and Anhui.
Yujunjun graduated from Zhejiang University of Commerce and Industry with a master's degree in business administration and a bachelor's degree in chemistry.
joined Pfizer as Senior Regional Manager in early February 2012 and has been responsible for the promotion of ru'xian breast cancer chemotherapy products and Aibo's new product line.
promoted to manager of the East Region in June 2019, leading the Su-Yuan team to achieve new breakthroughs in performance, beda and innovation.
Huang Xu, Three-star Senior Medical Information Communication Area Manager, Cancer Business Group II East 2nd District, Hangzhou.
is responsible for the sales management of breast tumor products in Zhejiang, Jiangxi and Fujian.
Mr. Cai Xiangxuan, Senior Medical Information Communication Regional Manager of The Second Group of Oncology Business, Guangzhou, is responsible for the sales management of breast tumor product lines in Guangdong, Guangxi, Hubei, Hunan and Hainan.